Upregulated Cellular Expression of IL-17 by CD4+ T-Cells in Osteoporotic Postmenopausal Women
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Aim: The study aimed to investigate cellular expression of IL-17 by CD4+ T-cells in osteoporotic postmenopausal women. Methods: We enrolled 25 postmenopausal women with osteoporosis (PostMO) and 25 postmenopausal women with normal bone mineral density measurements (PostM) to examine the production of IL-17, tumor necrosis factor a (TNFa) and receptor activator of nuclear factor γ-B ligand (RANKL) by CD4+ T-cells and IL-17, RORγt, TNFa and RANKL mRNA levels in CD4+ T-cells. Circulating concentrations of IL-17 along with IL-6, TNFa, RANKL and osteoprotegerin (OPG) were also determined. Results: Osteoporotic postmenopausal women had higher serum concentrations of IL-17 (3.7 ± 1.3 vs. 2.5 ± 1.1 ng/ml, p = 0.042), IL-6 (158 ± 56 vs. 105 ± 39 pg/ml, p = 0.044), TNFa (138 ± 41 vs. 74 ± 11 pg/ml, p < 0.001) and OPG (1.7 ± 0.4 vs. 1.3 ± 0.4 ng/ml, p = 0.039) than healthy controls. The IL-17-producing CD4+ T-cells were higher in the PostMO group than in the PostM group (7.1 ± 2.4 vs. 4.9 ± 1.4%, p = 0.0015). Additionally, osteoporotic postmenopausal women had greater mRNA levels of IL-17 (3.5 ± 2.9 vs. 1.2 ± 1.0%, p = 0.019) and RORγt (5.7 ± 2.5 vs. 2.2 ± 1.0%, p < 0.001) in CD4+ T-cells than in healthy controls. Conclusions: Our findings implied that the upregulated production of IL-17 may play an important role in regulating bone loss in osteoporotic postmenopausal women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Zhao et al. (2016), who showed that osteoporotic postmenopausal women express increased levels of proinflammatory cytokines (TNF, IL-1, IL-6, or IL-17) when compared to their non-osteoporotic counterparts [20].”
From Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics (2023) · cites this paper as [20]
Citations
Cites
Lam, J., Takeshita, S., Barker, J. E., Kanagawa, O., Ross, F. P., & Teitelbaum, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11176 · Cited by 1,440
Skeletal remodeling in health and disease
Zaidi, M. (2007) · Nature Medicine · doi:10.1038/nm1593 · Cited by 1,069
Estrogen Prevents Bone Loss via Estrogen Receptor α and Induction of Fas Ligand in Osteoclasts
Nakamura, T., Imai, Y., Matsumoto, T., Sato, S., Takeuchi, K., Igarashi, K., Harada, Y., Azuma, Y., Krust, A., Yamamoto, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.025 · Cited by 1,013
Estrogen deficiency and bone loss: an inflammatory tale
Weitzmann, M. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28550 · Cited by 990
Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α
Cenci, S., Weitzmann, M. N., Roggia, C., Namba, N., Novack, D., Woodring, J., & Pacifici, R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11066 · Cited by 705
Roggia, C., Gao, Y., Cenci, S., Weitzmann, M. N., Toraldo, G., Isaia, G., & Pacifici, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251534698 · Cited by 513
Kurihara, N., Bertolini, D., Suda, T., Akiyama, Y., & Roodman, G. D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.11.4226 · Cited by 486
Yano, K., Tsuda, E., Washida, N., Kobayashi, F., Goto, M., Harada, A., Ikeda, K., Higashio, K., & Yamada, Y. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.4.518 · Cited by 363
Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival
Krum, S. A., Miranda‐Carboni, G. A., Hauschka, P. V., Carroll, J. S., Lane, T. F., Freedman, L. P., & Brown, M. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601984 · Cited by 353
Lubberts, E., van den Bersselaar, L., Oppers-Walgreen, B., Schwarzenberger, P., Coenen-de Roo, C. J. J., Kolls, J. K., Joosten, L. A. B., & van den Berg, W. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2655 · Cited by 348
D'Amelio, P., Grimaldi, A., Di Bella, S., Brianza, S. Z. M., Cristofaro, M. A., Tamone, C., Giribaldi, G., Ulliers, D., Pescarmona, G. P., & Isaia, G. (2008) · Bone · doi:10.1016/j.bone.2008.02.017 · Cited by 331
Tyagi, A. M., Srivastava, K., Mansoori, M. N., Trivedi, R., Chattopadhyay, N., & Singh, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044552 · Cited by 326
Jilka, R. L., Takahashi, K., Munshi, M., Williams, D. C., Roberson, P. K., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1039 · Cited by 212
Bellido, T., Stahl, N., Farruggella, T. J., Borba, V, Yancopoulos, G. D., & Manolagas, S. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118432 · Cited by 164
Zheng, S. X., Vrindts, Y., Lopez, M., De Groote, D., Zangerle, P. F., Collette, J., Franchimont, N., Geenen, V., Albert, A., & Reginster, J. Y. (1997) · Maturitas · doi:10.1016/s0378-5122(96)01080-8 · Cited by 150
Role of T cells in ovariectomy induced bone loss—revisited
Pacifici, R. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1500 · Cited by 142
Interleukin-17 Acts Independently of TNF-α under Arthritic Conditions
Koenders, M. I., Lubberts, E., van de Loo, F. A. J., Oppers-Walgreen, B., van den Bersselaar, L., Helsen, M. M., Kolls, J. K., Di Padova, F. E., Joosten, L. A. B., & van den Berg, W. B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6262 · Cited by 129
Devlin, R. D., Reddy, S. V., Savino, R., Ciliberto, G., & Roodman, G. D. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.3.393 · Cited by 126
IL‐17 mediates estrogen‐deficient osteoporosis in an Act1‐dependent manner
DeSelm, C. J., Takahata, Y., Warren, J., Chappel, J. C., Khan, T., Li, X., Liu, C., Choi, Y., Kim, Y. F., Zou, W., et al. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24165 · Cited by 125
McNamara, L. M. (2010) · Journal of The Royal Society Interface · doi:10.1098/rsif.2009.0282 · Cited by 124
Circulating levels of cytokines that modulate bone resorption: Effects of age and menopause in women
Mckane, W. R., Khosla, S., Peterson, J. M., Egan, K., & Riggs, B. L. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090821 · Cited by 105
Zhao, R. (2012) · International Journal of Medical Sciences · doi:10.7150/ijms.5180 · Cited by 93
Self-citationProminent Bone Loss Mediated by RANKL and IL-17 Produced by CD4+ T Cells in TallyHo/JngJ Mice
Won, H. Y., Lee, J.-A., Park, Z. S., Song, J. S., Kim, H. Y., Jang, S.-M., Yoo, S.-E., Rhee, Y., Hwang, E. S., & Bae, M. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018168 · Cited by 91
D'Amelio, P., Grimaldi, A., Pescarmona, G. P., Tamone, C., Roato, I., & Isaia, G. (2005) · The FASEB Journal · doi:10.1096/fj.04-2214fje · Cited by 80
Zhang, J., Fu, Q., Ren, Z., Wang, Y., Wang, C., Shen, T., Wang, G., & Wu, L. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2014.975683 · Cited by 79
High prevalence of increased interleukin-17A serum levels in postmenopausal estrogen deficiency
Molnár, I., Bohaty, I., & Somogyiné-Vári, É. (2014) · Menopause · doi:10.1097/gme.0000000000000125 · Cited by 66
Immune regulation of bone loss by T h17 cells in oestrogen‐deficient osteoporosis
Zhao, R. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12158 · Cited by 66
Self-citationIL-17A-mediated sRANK ligand elevation involved in postmenopausal osteoporosis
Molnár, I., Bohaty, I., & Somogyiné-Vári, É. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2548-6 · Cited by 56
Cited by
Li, J., Chen, X., Lu, L., & Yu, X. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.02.003 · Cited by 273
Osteoporosis: Pathophysiology and therapeutic options
Föger‐Samwald, U., Dovjak, P., Azizi-Semrad, U., Kerschan‐Schindl, K., & Pietschmann, P. (2020) · EXCLI journal · doi:10.17179/excli2020-2591 · Cited by 257
“…of proinflammatory cytokines in osteoporosis is strengthened by the findings of elevated levels of TNF, IL-1, IL-6, or IL-17 in the first ten years after menopause (Pacifici et al., 1990) and in osteoporotic postmenopausal women compared to non-osteoporotic postmenopausal women (Zhao et al., 2016).”
BackgroundT-Cell Mediated Inflammation in Postmenopausal Osteoporosis
Wu, D., Cline-Smith, A., Shashkova, E., Perla, A., Katyal, A., & Aurora, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.687551 · Cited by 227
Dar, H. Y., Shukla, P., Mishra, P. K., Anupam, R., Mondal, R. K., Tomar, G. B., Sharma, V., & Srivastava, R. K. (2018) · Bone Reports · doi:10.1016/j.bonr.2018.02.001 · Cited by 194
“In humans, estrogen deficiency is associated with an expansion of RANKL and TNF-α expressing T cells (Zhao et al., 2016).”
BackgroundMolecular and Cellular Mechanisms of Osteoporosis
Zhivodernikov, I. V., Kirichenko, T. V., Markina, Y. V., Postnov, A. Y., & Markin, A. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115772 · Cited by 166
“Postmenopausal women with osteoporosis have higher concentrations of serum IL-17A, RANKL, and OPG and more IL-17-producing CD4+ T-cells in the peripheral blood [14,15].”
Background
Metadata
- Authors
- Zhao, R., Wang, X., & Feng, F.
- Affiliations
- Zhejiang Normal University (CN)
- ORCID
- Zhao, Renqing
- Venue
- Annals of Nutrition and Metabolism
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 68
- Issue
- 2
- Pages
- 113-118
- ISSN
- 0250-6807 (ISSN-L)
- 1421-9697
- OpenAlex
- W2290918810
- Cited by
- 51
- References
- 28
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 8 · 2023: 4 · 2022: 4 · 2021: 8 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 2
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Annals of Nutrition and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- IL-17, CD4+ T cells, postmenopausal osteoporosis, bone loss, RORγt, TNF-α, RANKL, osteoprotegerin, interleukin-6, bone remodeling, cytokines, postmenopausal women, bone mineral density, mRNA expression, serum cytokines
- MeSH terms
- Aged, Female, Humans, Middle Aged, Tumor Necrosis Factor-alpha, CD4-Positive T-Lymphocytes, Bone Density, Osteoporosis, Postmenopausal, Up-Regulation, Cytokines, Postmenopause, Interleukin-17, Asian People, Osteoprotegerin, RANK Ligand, Nuclear Receptor Subfamily 1, Group F, Member 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.